You are here

2017 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

PLEASE NOTE: All assets on this page are intended for use by media professionals.

Pfizer at ASCO 2017

Pfizer Oncology will present new data across its oncology portfolio at the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) being held from June 2-6 in Chicago. Please visit the links below for information on Pfizer Oncology and multiple oncology programs being showcased at ASCO.

Click here to learn more about how Pfizer Oncology is working to improve the outlook for people living with cancer.

Click here to learn more about Pfizer's unique combination approach and pipeline.

Press Releases

ASCO_download_pdf_media_block_940x140

 

ASCO_download_pdf_media_block_940x140

Hear from Pfizer Leadership

2017_ASCO_Albert_Bourla.pngRALLYING A GLOBAL MOVEMENT TO FIGHT CANCER » Albert Bourla

Group President, Pfizer Innovative Health

2017_ASCO_Liz_Barrett.pngCOMING TOGETHER TO CONQUER CANCER: HOW TO TURN PROMISE INTO REALITY » Liz Barrett

Global President and General Manager, Pfizer Oncology

2017_ASCO_Matthew_Shaulis.pngTO REDUCE FINANCIAL BURDEN FOR PATIENTS, WE NEED COOPERATION AND COORDINATION » Matthew Shaulis

President, North America Oncology at Pfizer

2017_ASCO_Mace_Rothenberg.pngPIECING IT TOGETHER: SOLVING THE PUZZLE OF CANCER » Mace Rothenberg, MD

Chief Development Officer, Oncology, Pfizer Global Product Development

Videos

TRANSFORMING THE FUTURE OF BREAST CANCER THROUGH SCIENTIFIC INNOVATION

Hear from Maria Koehler, MD, PhD and Matthew Ellis, MD about recent progress.

PFIZER TALKS POSSIBILITIES

Taking the temperature of immuno-oncology.

Pfizer Oncology B-Roll

Includes footage of Pfizer headquarters, research facilities and a physician/patient exam for use by media outlets.

Pfizer Immuno-oncology Video

Recent immunotherapy advances represent new hope for patients with cancer. At Pfizer, we’re primed to go further – and take the next big leap in immuno-oncology.